argenx (Euronext & Nasdaq: ARGX) has completed its acquisition of Forte Biosciences, Inc. (Nasdaq: FBRX) through a cash tender offer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE